
School of Molecular and Veterinary Medicine University of Edinburgh¤ÎJohn M.S. Bartlett»á
¡¡¥¨¥¹¥È¥í¥²¥ó¤ÎÀ¸¹çÀ®¤òÁ˳²¤¹¤ë¥¢¥í¥Þ¥¿¡¼¥¼Á˳²ºÞ¡ÊAI¡Ë¤Ï³«È¯¤¬¿Ê¤ß¡¢Âè3À¤Âå¤ÎAI¤Î³èÀ¤Î¹â¤µ¤¬¼¨¤µ¤ì¤Æ¤¤¤ë¡£ÊķиåÆý´â¤ËÂФ¹¤ë¥Û¥ë¥â¥óÎÅË¡¤Ç¤Ï¥¿¥â¥¥·¥Õ¥§¥ó¤¬Ã濴Ū¤ÊÌò³ä¤ò²Ì¤¿¤·¤Æ¤¤¿¤¬¡¢AI¤ÎÅоì¤Ë¤è¤ê¼£ÎÅÁªÂò»è¤ÏÂ礤¯¹¤¬¤Ã¤Æ¤¤¤ë¡£
¡¡6·î24Æü¤«¤é25Æü¤Þ¤Ç»¥ËڻԤdz«ºÅ¤µ¤ì¤¿Âè18²óÆüËÜÆý´â³Ø²ñ³Ø½ÑÁí²ñ¤Î¥é¥ó¥Á¥ç¥ó¥»¥ß¥Ê¡¼¡ÖPredictive and prognostic markers of endocrine therapy for early breast cancer¡×¡ÊºÂĹ¡§·§ËÜÂç³ØÂç³Ø±¡À¸Ì¿²Ê³Ø¸¦µæÉôÆýÁ£ÆâʬÈç³°²Ê¶µ¼ø¤Î´äÀ¥¹°·É»á¡¢¶¦ºÅ¡§¥Õ¥¡¥¤¥¶¡¼³ô¼°²ñ¼Ò¡Ë¤Ç¤Ï¡¢±Ñ¹ñUniversity of Edinburgh¤ÎSchool of Molecular and Veterinary Medicine¤Ç¶µ¼ø¤ò̳¤á¤ëJohn M.S. Bartlett»á¤¬¹Ö±é¤·¤¿¡£
¡¡Bartlett»á¤Ï¡¢Êķиå¤ÎÁá´üÆý´â¤ËÂФ¹¤ë¥¨¥¥»¥á¥¹¥¿¥ó¡Ê¾¦ÉÊ̾¡§¥¢¥í¥Þ¥·¥ó¡Ë¤ÎÍÍÑÀ¤ò¸¡Æ¤¤·¤¿TEAM¡ÊTamoxifen Exemestane Adjuvant Multinational¡Ë»î¸³¤ò²òÀ⤷¡¢AI¤Î¸ú²Ì¤òͽ¬¤¹¤ë¥Þ¡¼¥«¡¼¤ò´Þ¤á¡¢º£¸å¤ÎŸ˾¤Ë¤Ä¤¤¤Æ½Ò¤Ù¤¿¡£
¾ÜºÙ¤Ï¤³¤Á¤é¡ÊPDF¥Õ¥¡¥¤¥ë¤òÊÌ¥¦¥£¥ó¥É¥¦¤Ç³«¤¤Þ¤¹¡Ë